Published October 2000 | Version v1
Journal article

The clinical applications of labelling immunoassay in the cardiovascular disease and its progress

Creators

  • 1. Suzhou NO2. People's Hospital, JS (China). Dept. of Nuclear Medicine

Description

The disadvantage of radioimmunoassay are radio contamination and can not automate. In the date, the labelling immunoassay (enzyme immunoassay, fluorescent immunoassay, luminescent immunoassay) will eventually replace radioimmunoassay. The author reviews the clinical application of in the cardiovascular disease by labelling immunoassay thyroid hormone (TH), endothelin (ET), cytokine (CK), collagen, amino-terminal pro-peptide of type III pro-collagen (PIII NP), telopeptide of type I collagen (ICTP), myoglobin (Mb, cytokine isoenzyme cardio-muscle troponin I), growth hormone (GH), c-reactive protein (CRP), tumor necrosis factor-α(TNF-α), carbohydrate antigen-125 (CA-125), neuropeptide Y(NPY) and it's progress

Additional details

Publishing Information

Journal Title
Foreign Medicine Radiological Medicine and Nuclear Medicine Section
Journal Volume
24
Journal Issue
5
Journal Page Range
p. 193-196
ISSN
1001-098X